Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Tempest Therapeutics Inc
TPST
Healthcare
Biotechnology
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are Amezalpat and TPST-1495. Amezalpat is an oral, small molecule, selective antagonist of...
peroxisome proliferator-activated receptor alpha. The ongoing global randomized Phase Ib/II trial of Amezalpat combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma. The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, a pathway implicated in multiple cancers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TPST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(93)
•••
Tulsa123
X
Post by
Tulsa123
on Dec 15, 2024 8:50am
What news to come?
Good week
(93)
•••
Tulsa123
X
Post by
Tulsa123
on Nov 10, 2024 8:41am
Good choice?
Interested in owning stocks. What do you suggest? Tx
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 3:25am
Tempest Therapeutics, Inc. (NASDAQ:TPST): A Promising Oncolo
https://beyondspx.com/2024/08/01/tempest-therapeutics-inc-nasdaqtpst-a-promising-oncology-pipeline-backed-by-solid-financials/
(664)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 03, 2024 12:36pm
This company is so tight it squeaks , 22 million SO .
Moose Jaw
(664)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 01, 2024 3:03pm
What is going on with this volume ?
.
(664)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 01, 2024 2:04pm
Is this the run to 50 ?
mom says yes
(51)
•••
TheProphetElijah
X
Comment by
TheProphetElijah
on Nov 22, 2023 2:05pm
RE:RE:RE:TPST ....$7 Holla now
Thin float might hit $20 next run, fingers crossed for more good results.
(664)
•••
Galaxym31
X
Comment by
Galaxym31
on Nov 22, 2023 11:55am
RE:RE:TPST ....$7 Holla now
yes
(51)
•••
TheProphetElijah
X
Comment by
TheProphetElijah
on Nov 21, 2023 2:37pm
RE:TPST ....$7 Holla now
Does anyone expect this to go back to $10 dolla?
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 08, 2023 5:17pm
New Press Release - Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC studyNew capital strengthens balance sheet and extends cash runway into 2025BRISBANE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...
read article.
(1)
•••
Red~One
X
Post by
Red~One
on Oct 11, 2023 3:51pm
Wow congrats Isenechal
Holy man congrats people TPST trading at .20 yesterday....up to $7.59 today but we all know that Penny stocks are no good Tempest Therpeutics Inc up 2,938.77%
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 11, 2023 2:42pm
TPST ....$7 Holla now
I coulda been a contendah !!!!
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 11, 2023 2:31pm
TPST .....$6 holla....and still halted
Sheesh
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 11, 2023 2:09pm
TPST....looks like this is going to go higher
Me no position
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 11, 2023 1:58pm
TPST ...ramping up again!!!!
Lets see what happens
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
How Web3 Will Fundamentally Reshape Finance